ARCHIVES

FDA Panel urges Breast Implant Studies, Says Devices Should Remain Available

This article is from The Cancer Letter archive.

Vol. 17 No. 45 | November 22, 1991

Download PDF Visit The Full Archive

Related Articles

FDA Needs Staff, Funds But first Must Determine Priorities, GAO Says

November 17, 1989

NCI declined to pay for economic, quality of life analysis in Avastin, Erbitux study.

June 3, 2005

Two Sarcoma Drugs Pose Classic Question: How Much PFS Does it Take to Get a Nod?

March 30, 2012

ODAC Discussion: NCI’s Richard Simon Cautions About Rules Of Thumb

January 30, 2009

Institutions Fail To Credit NIH when Patenting discoveries, HHS Says

July 15, 1994

CMS Considering Regulatory Standards for Drug Company Bundling of Products.

October 20, 2006